Men with genetically elevated tyrosine levels appear to live, on average, nearly one year less than men with lower levels of the amino acid. That single statistic, drawn from a dataset of more than 270,000 people, landed quietly in the scientific literature in late 2025, then traveled far wider when major coverage followed in June 2026. The finding is surprising not because tyrosine is obscure, but because it’s the opposite: it’s a supplement ingredient lifespan researchers had largely overlooked, sold in mainstream products, stacked in pre-workout blends, and marketed explicitly for its brain-boosting, focus-sharpening properties.
What the data show is a correlation between higher circulating blood levels of tyrosine and reduced lifespan in men, with a proposed biological mechanism running through insulin resistance. The study examined naturally occurring blood levels rather than supplementation directly, which raises obvious and immediate questions about what high tyrosine levels actually mean, how they get elevated, and why the effect appears only in men.
Tyrosine is a building block for proteins and for a cluster of key neurotransmitters: dopamine, norepinephrine, and epinephrine. Those three chemicals regulate mood, attention, stress response, and motivation, which is precisely why tyrosine became a popular supplement ingredient. A compound that feeds dopamine and norepinephrine production sounds, at face value, like a reliable way to perform better under stress. Its long-term effects on aging, however, are a different story.
What Tyrosine Is and Why It’s in Your Supplement Stack
Amino acids act as the building blocks of proteins and support essential processes such as tissue repair and enzyme production. Alongside phenylalanine, tyrosine also plays a role in regulating metabolism and brain activity. It is naturally found in foods including meat, fish, eggs, and dairy products, and is also sold in supplements aimed at improving concentration, energy, and cognitive performance.
Tyrosine’s neurological profile explains its commercial popularity. A compound that feeds dopamine and norepinephrine production sounds like a reliable performance enhancer. Both tyrosine and phenylalanine are found in protein-rich foods and dietary supplements, but their long-term effects on aging are not well understood. That gap in understanding is precisely what the 2025 study set out to address.
The Study: Design, Scale, and a Supplement Ingredient Lifespan Signal
Researchers analyzed health and genetic data from more than 270,000 participants in the UK Biobank to examine whether these amino acids influence lifespan. The team was led by Jie V. Zhao, Yitang Sun, Junmeng Zhang, and Kaixiong Ye from the University of Hong Kong and the University of Georgia.
Their paper, published in the journal Aging in October 2025, examined whether levels of these nutrients in the blood are connected to lifespan. The study employed two methodological approaches, and the second separates this research from a standard observational correlation.
What Mendelian Randomization Actually Tells Us
Standard observational studies struggle with confounding: people who eat more protein-rich foods may also be wealthier, more sedentary, or have other lifestyle factors that independently affect lifespan. Mendelian randomization sidesteps this problem by using genetic variants as a natural experiment. Some people are genetically predisposed to produce more tyrosine than others. By comparing the lifespan outcomes of people who carry the gene variants associated with higher tyrosine against those who don’t, researchers can estimate a causal effect that’s less contaminated by lifestyle confounders.
The method exploits the principle that genotypes are randomly inherited from parents to offspring and should not be related to potential confounding factors, reflecting their fixed nature and Mendel’s laws of inheritance. The authors themselves acknowledged the approach carries important limitations and assumptions, and that additional studies in other populations are needed to confirm the results.
The Core Findings
The paper found that higher tyrosine levels were associated with shorter lifespan in both observational and Mendelian randomization analyses. After controlling for phenylalanine, tyrosine remained linked to shorter lifespan specifically in men – a reduction of approximately 0.91 years – while no significant association appeared in women.
That sex-specific pattern is one of the study’s most notable features. The research also found hints that phenylalanine may play a separate role in cardiovascular disease and cancer risk, although it showed no independent association with lifespan once tyrosine was accounted for. Once the researchers controlled for tyrosine levels, phenylalanine’s apparent effects on longevity largely disappeared.
Why the Effect Appears in Men, Not Women
Hormone-related differences between men and women may explain why the effect was seen only in male participants. Men and women metabolize amino acids differently, and sex hormones – testosterone, estrogen, and their downstream effects on insulin sensitivity and metabolic rate – are prime candidates for why the same circulating tyrosine level might carry different biological consequences depending on sex.
Over long periods, chronic activation of these pathways may influence aging differently in men and women because of interactions with sex hormones such as testosterone and estrogen. Men already carry a baseline disadvantage in life expectancy relative to women across almost every population studied, and this research raises the possibility that tyrosine’s metabolic behavior under male hormonal conditions is one small but measurable contributing factor.
The study’s authors noted that this sex-specific pattern also points toward a potential avenue for research: if the mechanism is hormonal, then understanding how tyrosine interacts with testosterone or estrogen could eventually illuminate more targeted approaches to longevity medicine in men.
The Proposed Mechanism: Insulin Resistance
The researchers identified insulin resistance as the most plausible biological pathway through which elevated tyrosine might accelerate aging. Insulin resistance is a condition in which the body’s cells become less responsive to insulin, and it is linked to numerous age-related health problems, including type 2 diabetes, cardiovascular disease, and metabolic disorders.
A 2024 study published in the Journal of Cachexia, Sarcopenia and Muscle found that insulin resistance and diabetes are associated with increased risk of frailty and cardiovascular disease. The concern, then, is that persistently elevated tyrosine levels may contribute to or worsen insulin resistance, which in turn accelerates a cluster of age-related conditions.
Tyrosine may also affect the production of neurotransmitters involved in the body’s stress response. Over time, disruptions in these systems could potentially influence long-term health and aging. This secondary pathway – the chronic stress-axis hypothesis – posits that chronically elevated tyrosine continuously primes the adrenal and neurological systems in ways that exact a metabolic cost over decades. The researchers did not resolve which pathway is dominant; both remain plausible and are not mutually exclusive.
The UK Biobank: Why This Dataset Matters
The study analyzed data from the UK Biobank, a longitudinal health cohort that has recruited hundreds of thousands of middle-aged volunteers and tracked their health outcomes, blood biomarkers, and genetic profiles over many years. Working with that dataset gives researchers far more statistical power to detect modest effects – like a lifespan difference of under one year – than most single-center studies could provide. The advent of large, open-access population biobanks has made approaches like Mendelian randomization increasingly powerful tools for causal inference research.
The cohort is predominantly white and British, which the researchers acknowledged as a limitation. Whether the same tyrosine-lifespan association holds across different ethnic groups, dietary cultures, and healthcare systems remains to be established.
Read More: The Unexpected Positive Side Effect Creatine Has on Health
What This Means for Supplement Users
No one in this study was randomized to take a tyrosine supplement, and the research cannot tell us what happens to lifespan when someone adds a 500mg or 1000mg tyrosine capsule to their daily routine. The study examined naturally occurring blood levels of tyrosine, not the use of supplements. The findings do not prove that tyrosine supplementation shortens lifespan.
Although tyrosine is commonly marketed for enhancing focus and mental performance, the findings suggest that people with elevated tyrosine levels may benefit from dietary adjustments. Strategies such as moderating overall protein intake could help reduce tyrosine levels. Further studies will be needed to confirm the results in other populations and to better understand the biological mechanisms involved. Researchers also aim to explore whether diet or lifestyle changes can safely influence tyrosine levels.
For men currently taking tyrosine supplements, the most honest read of the evidence is this: there is no direct proof of harm from supplementation, but the study introduces a credible biological signal that higher blood levels of tyrosine are associated with shorter male lifespan. That signal is strong enough to warrant a conversation with a physician, particularly for men already managing insulin resistance, metabolic syndrome, or cardiovascular risk factors – conditions that represent the very biological pathways the study implicates.
The supplement industry markets tyrosine heavily for cognitive performance under stress. The evidence for those short-term cognitive benefits is real but modest. The evidence on long-term safety is, as this study illustrates, far less settled than the marketing suggests.
What Men Who Take Tyrosine Supplements Should Know
Tyrosine has been classified as generally recognized as safe for short-term use, but this study is among the first large-scale investigations to ask what elevated blood levels of this supplement ingredient lifespan research is now scrutinizing actually do to the body over decades. The answer, at least for men, is worth taking seriously.
For men who get tyrosine from food alone, the practical message is less alarming. Moderating overall protein intake is one potential lever if blood tyrosine were ever measured as elevated – though most people have no reason to test for it without a specific clinical concern. For women, the current evidence offers no signal for concern.
The broader takeaway applies to anyone reading supplement labels: short-term safety data does not answer questions about what happens over a lifetime. This study identified a biological signal in a dataset of 270,000 people using a method designed to reduce confounding. Whether supplementation can reproduce the kind of chronically elevated tyrosine levels that drove that signal remains untested. Until that question is answered, men with existing metabolic risk factors have the clearest reason to raise this with their doctor before continuing or starting tyrosine supplementation.
Disclaimer: The author is not a licensed medical professional. The information provided is for general informational and educational purposes only and is based on research from publicly available, reputable sources. It is not intended to constitute, and should not be relied upon as, medical advice, diagnosis, or treatment. Always consult a licensed physician or other qualified healthcare provider regarding any medical condition, symptoms, or medications. Do not disregard, avoid, or delay seeking professional medical advice or treatment because of information contained herein.
AI Disclaimer: This article was created with the assistance of AI tools and reviewed by a human editor.
